September 13, 2017
The Fifth Circuit on Tuesday affirmed a lower court's decision to toss allegations that Solvay Pharmaceuticals Inc. caused health care providers to wrongfully bill the government for three of its drugs in violation of the False Claims Act, saying the relators didn't offer sufficient evidence to back their claims.